We divided gliomas into high-risk or low-risk groups based on median signature, and found significant enrichment of older age, WHO grade 4, IDH-wildtype, 1p/19p intact, MGMT promoter unmethylation and mesenchymal subtype in the high-risk group. This evidence concerns the gene IDH1 and central nervous system cancer.